Hudson Canyon Capital Management Abbott Laboratories Transaction History

Hudson Canyon Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 02, 2023	SELL	$114.02 - $139.04 $1.62 Million - $1.97 Million	-14,169 Closed	0 $0
Q4 2021 Aug 02, 2023	SELL	$115.53 - $141.46 $79,253 - $97,041	-686 Reduced 4.62%	14,169 $1.99 Billion
Q3 2021 Aug 02, 2023	SELL	$116.66 - $129.06 $64,163 - $70,983	-550 Reduced 3.57%	14,855 $1.75 Billion
Q2 2021 Aug 02, 2023	SELL	$105.79 - $124.53 $123,562 - $145,451	-1,168 Reduced 7.05%	15,405 $1.79 Billion
Q1 2021 Aug 02, 2023	SELL	$108.84 - $128.23 $154,443 - $181,958	-1,419 Reduced 7.89%	16,573 $1.99 Billion
Q4 2020 Aug 02, 2023	BUY	$105.0 - $114.42 $1.89 Million - $2.06 Million	17,992 New	17,992 $1.97 Billion

3,134

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hudson Canyon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hudson Canyon Capital Management with notifications on news.